Peter Attia· MD
the overlap is so strong that I honestly think for those of you as listeners I don't know that it matters that much according to Juliet 90 9.6% of people who meet criteria for naphl D will also have the diagnosis of masle D
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the overlap is so strong that I honestly think for those of you as listeners I don't know that it matters that much according to Juliet 90 9.6% of people who meet criteria for naphl D will also have the diagnosis of masle D
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.